Replacing or Supplementing Automated Insulin Delivery With Inhaled Insulin: A 90-Day Randomized Controlled Trial
This proof-of-concept study demonstrated the safety and efficacy of TI, at a higher modified dose conversion, when added for mealtime control to an AID system or was used for glycemic control with basal insulin.
Authors
- Thomas Blevins (ORCID: https://orcid.org/0000-0003-3746-9606)
- Scott Lee (ORCID: https://orcid.org/0000-0003-4584-6758)
- Johanna Ulloa
- Kevin B. Kaiserman (ORCID: https://orcid.org/0000-0002-3215-4317)
- Christopher Jacobson (ORCID: https://orcid.org/0009-0004-6492-6280)
- Kevin Codorniz
- Jennifer Pleitez
- Joseph Sylvan
Institutions
- Loma Linda University (US)
- MannKind Corporation (United States) (US)
- Texas Diabetes & Endocrinology (US)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1177/19322968251388128
- Citations
- 2
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 3.04